Jim Cramer Explains Mad Money Caller How to Handle Eton Pharmaceuticals (ETON)
During the lightning round of the August 26 Mad Money episode, a caller asked whether it is time to “cut it off” or if Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals Inc. (ETON)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Opaleye Management James A. Silverman | 2,860,000 | $103,532,000 | 9.38% | |
| 2. | EcoR1 Capital Oleg Nodelman | 2,171,938 | $78,624,156 | 3.82% | |
| 3. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,175,951 | $42,569,426 | 1.41% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 310,879 | $11,253,820 | +83% | 0.03% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 249,182 | $9,020,387 | +202% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.82 | 2,930 | $46,364.03 | 85,000 | 2025-06-10 | Filing | |
| $15.82 | 5,000 | $79,119.50 | 2,770,000 | 2025-06-10 | Filing | |
| $7.98 | 10,000 | $79,814.00 | 2,770,000 | 2024-10-23 | Filing | |
| $7.03 | 3,970 | $27,905.92 | 82,070 | 2024-10-08 | Filing | |
| $7.03 | 30,000 | $210,876.00 | 2,760,000 | 2024-10-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.07 | 4,166 | $229,406.21 | 43,381 | 2026-10-06 | Filing | |
| $61.77 | 128 | $7,906.56 | 59,745 | 2026-08-28 | Filing | |
| $60.21 | 13,485 | $811,931.85 | 59,873 | 2026-08-28 | Filing | |
| $58.64 | 36,387 | $2,133,733.68 | 73,358 | 2026-08-28 | Filing | |
| $61.77 | 128 | $7,906.56 | 59,745 | 2026-08-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 157,802 | $8,125,225 | 0.06% | |
| 2. | 27,978 | $1,440,587 | 0.37% | |
| 3. | 15,230 | $784,193 | 0.02% | |
| 4. | 11,789 | $607,016 | 0.02% | |
| 5. | 1,700 | $87,533 | 0.01% |
News See All
Q2 Outliers: 16 Stocks Beating Earnings Estimates
Although technology and AI have remained central to the growth narrative in the second-quarter earnings season, the latest data shows that this season is not just a tech earnings story.
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals' (ETON) Growth Strategy
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) is one of the best oversold growth stocks to invest in now. H.C. Wainwright lifted the price target on Eton Pharmaceuticals, Inc.
10 Oversold Growth Stocks to Invest In Now
In this article, we will look at the 10 Oversold Growth Stocks to Invest In Now.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2026 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q1 2026 Earnings Call Transcript May 14, 2026Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were $0.1.
10 Best NASDAQ Growth Stocks to Buy and Hold Forever
In this article, we will discuss the 10 Best NASDAQ Growth Stocks to Buy and Hold Forever.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026Eton Pharmaceuticals, Inc. misses on earnings expectations.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript November 6, 2025Eton Pharmaceuticals, Inc. misses on earnings expectations.
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Thank you for standing by. My name is Alex, and I will be your conference operator for today.
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency
Eton Pharmaceuticals, Inc.